ADTRAN Q3 revenue misses on supply constraints
ADTRAN Q3 revenue misses on supply constraints
Overview
US networking solutions provider's Q3 revenue up 0.6% yr/yr but missed analyst expectations
Adjusted EPS for Q3 beat analyst expectations
Company cites supply challenges but notes growth in optical networking and hyperscale customers
Outlook
ADTRAN expects Q4 2026 revenue between $272 mln and $292 mln
Company sees Q4 2026 non-GAAP operating margin between 1.0% and 5.0%
Company says supply and cost pressures remain a focus for future quarters
Result Drivers
SUPPLY CHALLENGES - Co said ongoing supply constraints weighed on Q3 revenue performance
OPTICAL NETWORKING & HYPERSCALE - Co said growth in optical networking and with hyperscale customers supported results
AI INFRASTRUCTURE DEMAND - Co said expansion of AI infrastructure is driving new opportunities in cloud and service provider markets
Company press release: ID:nBw10CZqga
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue | Miss | $281.17 mln | $285.72 mln (7 Analysts) |
Q3 Adjusted EPS | Beat | $0.09 | $0.03 (6 Analysts) |
Q3 Loss Per Share |
| $0.10 |
|
Q3 Net Loss |
| $7.14 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the communications & networking peer group is "buy"
Wall Street's median 12-month price target for ADTRAN Holdings Inc is $14.45, about 130.2% above its November 2 closing price of $6.28
The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 13 three months ago
Reuters Recommended Reads
Nov 2 - Marvell doubles down on AI boom with costly $115 billion Lumentum deal
Nov 2 - Lumentum Q1 revenue slightly beats estimates on pump laser demand
Nov 2 - Calix reports profit beat in Q3, supported by AI-native subscriber growth
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Adtran Holdings
See all newsUS RESEARCH ROUNDUP-Amgen, Carmax, Pfizer
Adtran Holdings Inc Reports Results For The Quarter Ended September 30: Earnings Summary
ADTRAN Q3 revenue misses on supply constraints
Brief: ADTRAN Q3 Adjusted EPS USD 0.09 Vs. IBES Estimate USD 0.03
Brief: Adtran Holdings, Inc. Appoints Dr. Christian H. Terlinde To Board Of Directors